Proton pump inhibitors and all-cause mortality risk among cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Tables (1-3)

Sum=51

Publishing Process of This Article

Item

Count

Browse

Download

Sum=1

Jan 24, 2025 (publication date) through Oct 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Jan 24, 2025; 16(1): 99240
Published online Jan 24, 2025. doi: 10.5306/wjco.v16.i1.99240

Table 2 Hazard ratios (95%CIs) for all-cause mortality between new users of proton pump inhibitors compared with non-users

Outcome	PPI-users (n = 48452)	Non-users (n = 48452)	HR (95%CI)
At 1 year	8888	3272	2.72 (2.61-2.83)
At 2 years	13719	5276	2.66 (2.58-2.74)
Overall outcome during follow-up	23421	11656	2.34 (2.29-2.42)

PPI: Proton pump inhibitor; HR: Hazard ratio.

Citation: Krishnan A, Schneider CV, Walsh D. Proton pump inhibitors and all-cause mortality risk among cancer patients. World J Clin Oncol 2025; 16(1): 99240
URL: https://www.wjgnet.com/2218-4333/full/v16/i1/99240.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i1.99240